Format

Send to

Choose Destination
Clin Transl Oncol. 2014 Dec;16(12):1079-90. doi: 10.1007/s12094-014-1238-y. Epub 2014 Nov 1.

Clinical guide SEOM on venous thromboembolism in cancer patients.

Author information

1
Medical Oncology Service, Gregorio Marañón University General Hospital, Madrid, Spain, andresmunmar@hotmail.com.

Abstract

Venous thromboembolism (VTE) is a common event in cancer patients and one of the major causes of cancer-associated mortality and a leading cause of morbidity. In recent years, the incidence rates of VTE have notably increased; however, VTE is still commonly underestimated by oncologists. VTE is considered an adverse prognostic factor in cancer patients in all settings. In 2011 the Spanish Society of Medical Oncology (SEOM) first published a clinical guideline of prophylaxis and treatment of VTE in cancer patients. In an effort to incorporate evidence obtained since the original publication, SEOM presents an update of the guideline for thrombosis and cancer in order to improve the prevention and management of VTE.

PMID:
25366189
PMCID:
PMC4239786
DOI:
10.1007/s12094-014-1238-y
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center